– USA, IN – MBX Biosciences, a drug discovery company focused on rare endocrine diseases, today announced the closing of a $34.6 million Series A financing led by Frazier Healthcare Partners, with participation from OrbiMed, New Enterprise Associates, Indiana Philanthropic Venture Fund, Indiana Seed Fund III and Twilight Venture Partners II.…
– USA, WA – Vein Clinics of America, a Frazier Healthcare Partners portfolio company, today announced that its Board of Directors has appointed Alton Shader as President and Chief Executive Officer effective December 10.…
– USA, WA – Mavupharma (Mavu) announced today that it has secured $20 million in a Series A financing led by Frazier Healthcare Partners and joined by Alpine BioVentures.…
– USA, MI – Cirius Therapeutics, previously known as Octeta Therapeutics, announced today the completion of a Series A financing of up to $40 million led by Frazier Healthcare Partners and Novo A/S.…
– USA, CA – SutroVax, a biopharmaceutical company dedicated to the delivery of best-in-class conjugate vaccines and novel complex antigen-based vaccines to prevent serious infectious diseases, today announced the closing of a $60 million Series B financing.…